Assessing the validity of surrogate outcomes for ESRD: A meta-analysis

Min Jun, Tanvir Chowdhury Turin, Mark Woodward, Vlado Perkovic, Hiddo J. Lambers Heerspink, Braden J. Manns, Marcello Tonelli, Brenda R. Hemmelgarn

Research output: Contribution to journalArticle

Abstract

Validation of current and promising surrogate outcomes for ESRD in randomized controlled trials (RCTs) has been limited. We conducted a systematic review and meta-analysis of RCTs to further inform the ability of surrogate outcomes for ESRD to predict the efficacy of various interventions on ESRD. MEDLINE, EMBASE, and CENTRAL (from inception through September 2013) were searched. All RCTs in adults with proteinuria, diabetes, or CKD stages 1-4 or renal transplant recipients reporting ≥10 ESRD events and a surrogate outcome (change in proteinuria or doubling of serum creatinine [DSCR]) for ESRD during a ≥1-year follow-up were included. Two reviewers abstracted trial characteristics and outcome data independently. To assess the correlation between the surrogate outcomes and ESRD, we determined the treatment effect ratio (TER), defined as the ratio of the treatment effects on ESRD and the effects on the change in surrogate outcomes. TERs close to 1 indicate greater agreement between ESRD and the surrogate, and these ratios were pooled across interventions. We identified 27 trials (97,458 participants; 4187 participants with ESRD). Seven trials reported the effects on change in proteinuria and showed consistent effects for proteinuria and ESRD (TER, 0.82; 95% confidence interval, 0.59 to 1.16), with minimal heterogeneity. Twenty trials reported on DSCR. Treatment effects on DSCR were consistent with the effects on ESRD (TER, 0.98; 95% confidence interval, 0.85 to 1.14), with moderate heterogeneity. In conclusion, DSCR is generally a good surrogate for ESRD, whereas data on proteinuria were limited. Further assessment of the surrogacy of proteinuria using prospective RCTs is warranted.

Original languageEnglish (US)
Pages (from-to)2289-2302
Number of pages14
JournalJournal of the American Society of Nephrology
Volume26
Issue number9
DOIs
StatePublished - Sep 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Nephrology

Cite this

Jun, M., Turin, T. C., Woodward, M., Perkovic, V., Lambers Heerspink, H. J., Manns, B. J., Tonelli, M., & Hemmelgarn, B. R. (2015). Assessing the validity of surrogate outcomes for ESRD: A meta-analysis. Journal of the American Society of Nephrology, 26(9), 2289-2302. https://doi.org/10.1681/ASN.2014040396